Filing Details

Accession Number:
0001618835-20-000248
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-18 17:22:52
Reporting Period:
2020-11-17
Accepted Time:
2020-11-18 17:22:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1618835 Evofem Biosciences Inc. EVFM Pharmaceutical Preparations (2834) 208527075
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1726277 J. Justin File C/O Evofem Biosciences, Inc.
12400 High Bluff Drive, Suite 600
San Diego CA 92130
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-17 7,760 $2.17 258,168 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.16 to $2.18, inclusive. The reporting person undertakes to provide to Evofem Biosciences, Inc. (Evofem), any security holder of Evofem, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.